TerminatedNot applicableNCT04427254

Study of the Sars-Cov2 Neuroinvasiveness - COVID19

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Principal Investigator
Pierre BOURDILLON, MD
Fondation A. de Rothschild
Intervention
Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies(drug)
Enrollment
2 target
Eligibility
18 years · All sexes
Timeline
20202022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04427254 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials